Kura Oncology (KURA) Other Working Capital Changes (2014 - 2026)
Kura Oncology (KURA) posted quarterly Other Working Capital Changes of -$9.4 million for Q1 2026, down 127.3% year-over-year from $34.6 million in Q1 2025, and up 75.4% quarter-over-quarter from -$38.4 million in Q4 2025.
Kura Oncology (KURA) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Kura Oncology (KURA) has reported Other Working Capital Changes for 13 consecutive years, with -$9.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 127.3% year-over-year to -$9.4 million; the TTM figure through Mar 2026 stood at -$43.0 million (down 222.2% YoY), while the FY2025 annual figure was $1.0 million, up 37.6% from the prior year.
- Other Working Capital Changes climbed to -$9.4 million in Q1 2026 per KURA's latest filing, from -$38.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $10.3 million in Q3 2025 and bottomed at -$2.9 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged $1.7 million across 5 years, with a median of $1.0 million in 2025.
- On a YoY basis, Other Working Capital Changes climbed as much as 20369.82% in 2025 and fell as far as 16433.62% in 2025.
- Kura Oncology's Other Working Capital Changes stood at $17000.0 in 2022, then tumbled by 541.18% to -$75000.0 in 2023, then surged by 413.33% to $235000.0 in 2024, then slumped by 16433.62% to -$38.4 million in 2025, then soared by 75.4% to -$9.4 million in 2026.
- Business Quant data shows KURA's Other Working Capital Changes at -$9.4 million in Q1 2026, -$38.4 million in Q4 2025, and $15.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Kura Oncology | 966.11 Mn | 966.11 Mn | 20.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.36 Mn |
| Jun 30, 2026 | -10.36 Mn |
| Jun 30, 2026 | -10.36 Mn |
| Mar 31, 2026 | -9.44 Mn |
| Mar 31, 2026 | -9.44 Mn |
| Mar 31, 2026 | -9.44 Mn |
| Dec 31, 2025 | -38.38 Mn |
| Dec 31, 2025 | -38.38 Mn |
| Dec 31, 2025 | -38.38 Mn |
| Sep 30, 2025 | 15.66 Mn |
| Sep 30, 2025 | 15.66 Mn |
| Sep 30, 2025 | 15.66 Mn |
| Jun 30, 2025 | -10.83 Mn |
| Jun 30, 2025 | -10.83 Mn |
| Jun 30, 2025 | -10.83 Mn |
| Mar 31, 2025 | 34.59 Mn |
| Mar 31, 2025 | 34.59 Mn |
| Mar 31, 2025 | 34.59 Mn |
| Dec 31, 2024 | 235,000.00 |
| Dec 31, 2024 | 235,000.00 |